Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced it has raised $100 million in...
Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced the appointment of Christopher Slachta,...
Norwest-led Financing Will Bring FDA-Cleared IntelliSep® Test to Hospitals Nationwide to Support Early Detection and Treatment of Serious Condition
Cytovale, a commercial-stage medical diagnostics company focused...
Cytovale, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced the U.S. commercial launch of...
